Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 AEP785 | DOI: 10.1530/endoabs.70.AEP785

ECE2020 Audio ePoster Presentations Reproductive and Developmental Endocrinology (79 abstracts)

Structural analysis of the impact of a novel androgen receptor gene mutation in two adult patients with mild androgen insensitivity syndrome

Mirella Hage 1 , Delphine Drui 2 , Marie-Adèle Ecomard 3 , Sandra Mercier 4 , Anne Guiochon-Mantel 5 , Joelle Belaisch-Allart 6 , Laure Cazabat 1,7 , Philippe De Mazancourt 8 & Marie-Laure Raffin-Sanson 1,7


1Centre Hospitalier Universitaire Ambroise Paré, Service d’Endocrinologie de Diabétologie et de Nutrition, Boulogne Billancourt, France; 2Centre Hospitalier Universitaire Nantes, Service d’Endocrinologie, L’institut du Thorax, Nantes, France; 3Centre Hospitalier de Rambouillet, Rambouillet, France; 4Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, L’institut du Thorax, Nantes, France; 5Centre Hospitalier Universitaire Bicêtre, Service de Génétique Moléculaire, Pharmacogénétique et Hormonologie, Le Kremlin-Bicêtre, France; 6Centre Hospitalier des Quatre Villes, Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Sèvres, France; 7EA4340, Université de Versailles Saint-Quentin-en-Yvelines, UFR des sciences de la santé Simone Veil, F- 78423, Montigny-le-Bretonneux, France; 8Centre Hospitalier Universitaire Ambroise Paré, Laboratoire de Biochimie-Génétique Moléculaire, UMR1179, Boulogne Billancourt, France


Context: Androgen insensitivity syndrome (AIS) is a rare X-linked recessive disordercaused by mutations in the androgen receptor (AR) gene resulting in variable target tissue resistance to androgen action. The underlying molecular defect causes a spectrum of androgen dysfunction ranging from gynecomastia and/or infertility in mild AIS (MAIS) to variable degrees of ambiguous or undermasculinized genitalia in partial AIS to complete testicular feminization in complete AIS. To date, more than 800 different mutations in theAR gene have been identified.

Objective: We report a previously undescribed mutation in the AR gene associated with MAIS in two adult patients, one presenting for infertility and the other for a decrease in athletic performance. We characterize the functional impact of this mutation using 3D modeling studies.

Patients: Patient 1 was referred at the age of 38 years for infertility. He had gynecomastia and normal external genitaliaexcept for mild hypospadias. His semen analysis showed oligoasthenoteratospermia. Lab results revealed high testosterone levels, an elevated FSH, and an elevated androgen sensitivity index (ASI) suggesting AIS. The couple underwent successful in vitro fertilization and intracytoplasmic sperm injection resulting in a twin pregnancy. Patient 2 was referred at the age of 45 years for evaluation of a fatigue and a decrease in physical athletic performance. He had a history of gynecomastia, surgically treated during adolescencebut normal external genitalia. He alsopresented with oligoasthenoteratospermia, hightestosterone plasma levels and an elevated ASI. Despite his impairedsemen analysis, he fathered two children without assisted reproductive technology. Because of his persistent fatigue, the patient was offered a trial of high dose dihydrotestosterone therapy which improved his symptoms and his quality of life. Family history for infertility or gynecomastia was negative in both patients.

Results and conclusions: Sequence analysis of AR gene in the two patients revealed a common previously undescribed missense mutation, Ala699Thr, within the ligand binding domain. Structural analysis showed that this mutation may impact dimer stability upon ligand binding or may affect allosteric changes upon dimerization. This study highlights the usefulness of structural studies in providing a greater understanding of the functional consequences of a mutation and expands the databaseof AR gene mutations. The proper diagnosis of adult patients with MAIS may be helpful for the adequate counseling of infertile male patient undergoing assisted reproductive techniques. In addition, a trial of high dose androgen therapy may improve symptoms of hypogonadism in patients with MAIS.

Volume 70

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.